Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Withdrawal of Credit Rating.
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma has informed the stock exchanges that one of its credit ratings has been withdrawn under SEBI Listing Regulations. Credit rating withdrawals typically happen when the underlying instrument (like a loan or bond) has been fully repaid, redeemed, or closed, and there is no longer any outstanding obligation to maintain a rating. The company has not disclosed any reason for stress or financial difficulty in this filing. Investors should check which specific agency and instrument's rating was withdrawn for more context.
A credit rating withdrawal by itself is generally a routine disclosure and is not necessarily negative, but shareholders may want clarity on whether it signals debt prepayment or simply closure of a rated facility. Watch for any follow-up filings explaining the reason for the withdrawal.